Literature DB >> 3349554

Priming with anti-cholinesterases--the effect of different combinations of anti-cholinesterases and different priming intervals.

M Naguib1, M Abdulatif.   

Abstract

This study was designed to investigate the effect of different combinations of neostigmine and edrophonium when administered in divided doses and the effect of different intervals (priming intervals) between the doses. Seventy-two patients divided into 12 groups (n = 6 in each) were included in the study. An initial dose of neostigmine 0.012 mg.kg-1 or edrophonium 0.2 mg.kg-1 was administered, followed at different priming intervals (1, 2 or 3 min) by either edrophonium 0.8 mg.kg-1 or neostigmine 0.048 mg.kg-1 for antagonism of atracurium-induced neuromuscular blockade. Reversal was attempted at 10 per cent spontaneous recovery of twitch height. Adequate reversal of neuromuscular block (train-of-four ratio of 0.75) was achieved in all patients. Significant (p less than 0.05) acceleration of the recovery index (time taken for the twitch height to recover from 25 to 75 per cent of control) and reversal time (time taken from the end of injection of the priming dose until TOF ratio value had reached 0.75) was obtained in groups which received edrophonium-edrophonium combination. Recovery indices and reversal times were found to be significantly shorter (p less than 0.05) with a 1 min priming interval. In two additional groups of patients premedicated and anaesthetized as the others equipotent mixtures of the antagonists were administered as a single bolus dose. Reversal times were significantly longer (p less than 0.05) when compared to those given the same amounts of the combination but in divided doses with a 1 min priming interval.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3349554     DOI: 10.1007/BF03010544

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  15 in total

1.  Acetylcholinesterase studies on molecular complementariness.

Authors:  I B WILSON; C QUAN
Journal:  Arch Biochem Biophys       Date:  1958-01       Impact factor: 4.013

2.  The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium.

Authors:  H E Barber; T N Calvey; K T Muir
Journal:  Br J Pharmacol       Date:  1979-08       Impact factor: 8.739

Review 3.  Clinical assessment of neuromuscular transmission.

Authors:  J Viby-Mogensen
Journal:  Br J Anaesth       Date:  1982-02       Impact factor: 9.166

Review 4.  Antagonism of neuromuscular blockade.

Authors:  R Cronnelly; R B Morris
Journal:  Br J Anaesth       Date:  1982-02       Impact factor: 9.166

5.  Edrophonium and neostigmine for reversal of the neuromuscular blocking effect of vecuronium.

Authors:  J Engbaek; H Ording; D Ostergaard; J Viby-Mogensen
Journal:  Acta Anaesthesiol Scand       Date:  1985-07       Impact factor: 2.105

6.  Protein binding of atracurium and other short-acting neuromuscular blocking agents and their interaction with human cholinesterases.

Authors:  F F Foldes; A Deery
Journal:  Br J Anaesth       Date:  1983       Impact factor: 9.166

7.  Accelerated reversal of atracurium blockade with divided doses of neostigmine.

Authors:  M Abdulatif; M Naguib
Journal:  Can Anaesth Soc J       Date:  1986-11

8.  The margin of safety of neuromuscular transmission.

Authors:  W D Paton; D R Waud
Journal:  J Physiol       Date:  1967-07       Impact factor: 5.182

9.  The mechanism of the facilitatory action of edrophonium in cat skeletal muscle.

Authors:  L C Blaber
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

10.  Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium.

Authors:  S M Rupp; J W McChristian; R D Miller; J A Taboada; R Cronnelly
Journal:  Anesthesiology       Date:  1986-06       Impact factor: 7.892

View more
  5 in total

1.  "Priming" with neostigmine: failure to accelerate reversal of single twitch and train-of-four responses.

Authors:  F Donati; C E Smith; S Wiesel; D R Bevan
Journal:  Can J Anaesth       Date:  1989-01       Impact factor: 5.063

2.  Edrophonium priming for antagonism of atracurium neuromuscular blockade.

Authors:  J E Szalados; F Donati; D R Bevan
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

3.  Priming with anti-cholinesterases--the effect of different priming doses of edrophonium.

Authors:  M Naguib; M Abdulatif
Journal:  Can J Anaesth       Date:  1988-01       Impact factor: 5.063

4.  Edrophonium priming alters the course of neuromuscular recovery from a pipecuronium neuromuscular blockade.

Authors:  M Naguib; M Abdulatif
Journal:  Can J Anaesth       Date:  1991-09       Impact factor: 5.063

5.  Train-of-four ratio after antagonism of atracurium with edrophonium: influence of different priming doses of edrophonium.

Authors:  M Naguib
Journal:  Can J Anaesth       Date:  1989-01       Impact factor: 5.063

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.